NZ505880A - IL-18 receptor polypeptides - Google Patents
IL-18 receptor polypeptidesInfo
- Publication number
- NZ505880A NZ505880A NZ505880A NZ50588099A NZ505880A NZ 505880 A NZ505880 A NZ 505880A NZ 505880 A NZ505880 A NZ 505880A NZ 50588099 A NZ50588099 A NZ 50588099A NZ 505880 A NZ505880 A NZ 505880A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dna
- seq
- sequence presented
- polypeptide
- hybridising
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 102000004557 Interleukin-18 Receptors Human genes 0.000 title 1
- 108010017537 Interleukin-18 Receptors Proteins 0.000 title 1
- 108020004414 DNA Proteins 0.000 abstract 12
- 108091026890 Coding region Proteins 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 abstract 2
- 101710138729 Interleukin-18 receptor accessory protein Proteins 0.000 abstract 2
- 230000000295 complement effect Effects 0.000 abstract 2
- 238000009396 hybridization Methods 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7230198P | 1998-01-23 | 1998-01-23 | |
| US7883598P | 1998-03-20 | 1998-03-20 | |
| US9446998P | 1998-07-28 | 1998-07-28 | |
| PCT/US1999/001419 WO1999037772A1 (en) | 1998-01-23 | 1999-01-22 | Il-18 receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ505880A true NZ505880A (en) | 2003-06-30 |
Family
ID=27372056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ505880A NZ505880A (en) | 1998-01-23 | 1999-01-22 | IL-18 receptor polypeptides |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US6589764B1 (https=) |
| EP (1) | EP1047781B1 (https=) |
| JP (1) | JP4271850B2 (https=) |
| AT (1) | ATE272114T1 (https=) |
| AU (1) | AU737592B2 (https=) |
| CA (1) | CA2318482C (https=) |
| DE (1) | DE69918946T2 (https=) |
| DK (1) | DK1047781T3 (https=) |
| ES (1) | ES2226335T3 (https=) |
| IL (2) | IL137178A0 (https=) |
| NZ (1) | NZ505880A (https=) |
| PT (1) | PT1047781E (https=) |
| WO (1) | WO1999037772A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326472B1 (en) | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
| US6472179B2 (en) * | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| US7083949B2 (en) | 1998-09-25 | 2006-08-01 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US20020155526A1 (en) | 1998-09-30 | 2002-10-24 | Busfield Samantha J. | Novel secreted immunomodulatory proteins and uses thereof |
| US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
| JP4741139B2 (ja) * | 1999-12-23 | 2011-08-03 | ザイモジェネティクス， インコーポレイテッド | 可溶性インターロイキン−２０レセプター |
| US7122632B2 (en) | 1999-12-23 | 2006-10-17 | Zymogenetics, Inc. | Soluble Interleukin-20 receptor |
| TWI335336B (https=) | 2000-02-10 | 2011-01-01 | Abbott Gmbh & Co Kg | |
| US20020025317A1 (en) * | 2000-07-20 | 2002-02-28 | Schering Ag | Bispecific monoclonal antibodies to IL-12 and IL-18 |
| US20020052475A1 (en) * | 2000-07-20 | 2002-05-02 | Schering Ag | High affinity soluble interleukin-18 receptor |
| ES2381650T3 (es) | 2000-08-08 | 2012-05-30 | Zymogenetics, Inc. | Receptores de citoquinas Zcytor11 solubles |
| JP4908723B2 (ja) | 2000-09-15 | 2012-04-04 | ザイモジェネティクス， インコーポレイテッド | 炎症を治療するための方法 |
| CA2424983A1 (en) | 2000-10-11 | 2002-04-18 | Viron Therapeutics, Inc. | Nucleic acid molecules and polypeptides for immune modulation |
| US7718368B2 (en) * | 2000-12-04 | 2010-05-18 | Viron Therapeutics Inc. | Immunomodulatory protein and useful embodiments thereof |
| GB2375604A (en) * | 2001-05-18 | 2002-11-20 | Warner Lambert Co | Methods for screening using interleukin soluble trimolecular complex |
| PH12012502440A1 (en) | 2001-06-26 | 2013-06-17 | Amgen Inc | Antibodies to opgl |
| EP1293566A1 (en) * | 2001-09-17 | 2003-03-19 | Societe Des Produits Nestle S.A. | A soluble toll-like receptor |
| CA2467723C (en) | 2001-12-17 | 2011-09-27 | Zymogenetics, Inc. | Method for treating cervical cancer |
| AU2003259995B2 (en) | 2002-08-28 | 2009-07-02 | Immunex Corporation | Compositions and methods for treating cardiovascular disease |
| MXPA05003869A (es) | 2002-10-08 | 2005-06-22 | Ares Trading Sa | El uso de citocina capaz de enlazarse a la proteina de union a interleucina-18, y de inhibir la actividad de una segunda citocina. |
| EP1606316A2 (en) | 2003-03-24 | 2005-12-21 | ZymoGenetics, Inc. | Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| US20050100965A1 (en) | 2003-11-12 | 2005-05-12 | Tariq Ghayur | IL-18 binding proteins |
| US7968684B2 (en) * | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
| DE602004023965D1 (de) | 2003-11-21 | 2009-12-17 | Zymogenetics Inc | Anti-il-20-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen |
| US7141382B1 (en) | 2004-10-12 | 2006-11-28 | Parikh Chirag R | Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality |
| JP4898691B2 (ja) | 2004-10-22 | 2012-03-21 | ザイモジェネティクス， インコーポレイテッド | 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法 |
| AU2005327508A1 (en) * | 2005-02-15 | 2006-08-24 | Apollo Life Sciences Limited | Molecules and chimeric molecules thereof |
| JP2009527535A (ja) * | 2006-02-22 | 2009-07-30 | ユニバーシティ オブ チューリッヒ | 自己免疫疾患又は脱髄疾患を処置するための可溶性受容体及び方法 |
| JP5368301B2 (ja) | 2006-06-22 | 2013-12-18 | ノボ・ノルデイスク・エー／エス | 可溶性ヘテロ二量体レセプター及びその使用 |
| MX2009012343A (es) * | 2007-05-14 | 2010-02-10 | Biogen Idec Inc | Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello. |
| CL2008002153A1 (es) | 2007-07-24 | 2009-06-05 | Amgen Inc | Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r. |
| BR112012021576A2 (pt) | 2010-02-26 | 2016-10-25 | Novo Nordisk As | composições estáveis contendo anticorpo. |
| RU2012153786A (ru) | 2010-05-28 | 2014-07-10 | Ново Нордиск А/С | Стабильные многодозовые композиции, содержащие антитело и консервант |
| SG10201505217WA (en) | 2010-07-09 | 2015-08-28 | Biogen Hemophilia Inc | Chimeric clotting factors |
| JP5813114B2 (ja) | 2010-08-25 | 2015-11-17 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｉｌ−１８ｒ１に対する抗体およびその使用 |
| US9376489B2 (en) | 2012-09-07 | 2016-06-28 | Novartis Ag | IL-18 binding molecules |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989004838A1 (en) | 1987-11-25 | 1989-06-01 | Immunex Corporation | Interleukin-1 receptors |
| EP0533006A1 (en) * | 1991-09-18 | 1993-03-24 | F.Hoffmann-La Roche & Co. Aktiengesellschaft | Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
| US5470952A (en) | 1993-10-20 | 1995-11-28 | Regeneron Pharmaceuticals, Inc. | CNTF and IL-6 antagonists |
| WO1996013593A2 (en) * | 1994-10-26 | 1996-05-09 | Procept, Inc. | Soluble single chain t cell receptors |
| US5853721A (en) | 1995-01-31 | 1998-12-29 | Hoffmann-La Roche Inc. | Antibody to interleukin-12 receptor |
| US5840530A (en) * | 1995-08-01 | 1998-11-24 | Hoffmann-La Roche Inc. | DNA encoding receptors for the beta-2 chain of human IL-12 |
| US5776731A (en) | 1996-02-21 | 1998-07-07 | Immunex Corporation | DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| US7141393B2 (en) | 1996-12-26 | 2006-11-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18-receptor proteins |
| US6087116A (en) | 1997-03-12 | 2000-07-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18 (IL-18) receptor polypeptides and their uses |
| US6326472B1 (en) | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
| US6280955B1 (en) * | 1997-12-16 | 2001-08-28 | Tularik Inc. | Interleukin-1 receptor accessory proteins, nucleic acids and methods |
| US6472179B2 (en) | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| US20020052475A1 (en) | 2000-07-20 | 2002-05-02 | Schering Ag | High affinity soluble interleukin-18 receptor |
-
1999
- 1999-01-22 EP EP99904222A patent/EP1047781B1/en not_active Expired - Lifetime
- 1999-01-22 ES ES99904222T patent/ES2226335T3/es not_active Expired - Lifetime
- 1999-01-22 CA CA2318482A patent/CA2318482C/en not_active Expired - Fee Related
- 1999-01-22 DE DE69918946T patent/DE69918946T2/de not_active Expired - Lifetime
- 1999-01-22 NZ NZ505880A patent/NZ505880A/xx not_active IP Right Cessation
- 1999-01-22 PT PT99904222T patent/PT1047781E/pt unknown
- 1999-01-22 IL IL13717899A patent/IL137178A0/xx active IP Right Grant
- 1999-01-22 WO PCT/US1999/001419 patent/WO1999037772A1/en not_active Ceased
- 1999-01-22 AT AT99904222T patent/ATE272114T1/de active
- 1999-01-22 JP JP2000528679A patent/JP4271850B2/ja not_active Expired - Fee Related
- 1999-01-22 DK DK99904222T patent/DK1047781T3/da active
- 1999-01-22 AU AU24668/99A patent/AU737592B2/en not_active Ceased
-
2000
- 2000-07-05 IL IL137178A patent/IL137178A/en not_active IP Right Cessation
- 2000-07-21 US US09/621,502 patent/US6589764B1/en not_active Expired - Fee Related
-
2003
- 2003-05-15 US US10/439,458 patent/US7169581B2/en not_active Expired - Fee Related
-
2007
- 2007-01-29 US US11/699,676 patent/US7704945B2/en not_active Expired - Fee Related
-
2010
- 2010-03-03 US US12/716,993 patent/US8053233B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1047781A1 (en) | 2000-11-02 |
| PT1047781E (pt) | 2004-11-30 |
| IL137178A (en) | 2007-06-17 |
| US20030199040A1 (en) | 2003-10-23 |
| CA2318482A1 (en) | 1999-07-29 |
| US20070135625A1 (en) | 2007-06-14 |
| US7169581B2 (en) | 2007-01-30 |
| US20100190211A1 (en) | 2010-07-29 |
| DK1047781T3 (da) | 2004-12-06 |
| ES2226335T3 (es) | 2005-03-16 |
| CA2318482C (en) | 2010-04-13 |
| DE69918946D1 (de) | 2004-09-02 |
| AU737592B2 (en) | 2001-08-23 |
| US6589764B1 (en) | 2003-07-08 |
| WO1999037772A1 (en) | 1999-07-29 |
| US7704945B2 (en) | 2010-04-27 |
| JP2002500886A (ja) | 2002-01-15 |
| AU2466899A (en) | 1999-08-09 |
| EP1047781B1 (en) | 2004-07-28 |
| JP4271850B2 (ja) | 2009-06-03 |
| DE69918946T2 (de) | 2005-07-28 |
| IL137178A0 (en) | 2001-07-24 |
| ATE272114T1 (de) | 2004-08-15 |
| US8053233B2 (en) | 2011-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ505880A (en) | IL-18 receptor polypeptides | |
| PL332851A1 (en) | Novel homoloques of fibroblast growth factor | |
| BG102973A (en) | LIGAND RET (RetL) FOR THE STIMULATION OF THE NERVE AND RENAL GROWTH | |
| CA2172989A1 (en) | Conotoxin peptides | |
| CA2269111A1 (en) | Genes encoding plant transcription factors | |
| WO2003008446A1 (fr) | Polypeptides se rapportant au transfert de signaux de recepteur de produits terminaux a glycation avancee | |
| CA2204257A1 (en) | Tripeptidyl aminopeptidase | |
| AU8009601A (en) | Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same | |
| CA2461443A1 (en) | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use | |
| EP1092727A3 (en) | G-protein receptor | |
| AU3230797A (en) | Dna encoding dp. 75 and a process for its use | |
| JP2004505640A5 (https=) | ||
| WO1999009054A3 (en) | Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders | |
| IL142709A0 (en) | Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof | |
| MX9603876A (es) | Procedimiento intermitente de digestion para producir pulpa deslignficada. | |
| GB9416536D0 (en) | Orphan receptor | |
| AU2043597A (en) | Human taki dna encoding the same | |
| JP2002538775A5 (https=) | ||
| CA2448347A1 (en) | Novel human hydroxylases and polynucleotides encoding the same | |
| GB2356864B (en) | Novel polypeptide | |
| SE9801098D0 (sv) | Receptors | |
| YU29801A (sh) | Gen prv-1 i njegova primena | |
| WO2001012665A3 (en) | Helical cytokine zalpha48 | |
| NZ505350A (en) | DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours | |
| SE0001988D0 (sv) | Novel polypeptides and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| EXPY | Patent expired |